Teva’s Baeder: We Need To ‘Crack The Nut’ Of Complex Generics

US Generics Division COO Says Optimum Environment Needs To Be Created

 
• By David Wallace
  
Christine Baeder
Teva’s Christine Baeder sets out her view of complex generics in the US • Source: Teva
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business